TF

Todd Foley

Managing Director at MPM BioImpact

Boston, Massachusetts

VC
Investor

Invests in

  • Min Investment:

    $1,000,000.00

  • Max Investment:

    $150,000,000.00

  • Target Investment:

    $25,000,000.00

Skills

Venture Capital
Corporate Development
Private Equity
Due Diligence
Biotechnology

Education

Lists including Todd

AM
AR
AB
AF

Based in Boston & Cambridge

668 people

AT
AS
AT
AH

All Series A Investors

14752 people

AM
AT
AS
AR

All Seed Investors

19695 people

AT
AE
AE
AL

All Pre-Seed Investors

7974 people

SF
SS
ST
SJ

Pre-Seed Investors in Boston

71 people

Investments

āshibio

Series A

Total Funding: $40M

Firefly Bio

Series A

Total Funding: $94M

Crossbow Therapeutics

Series A

Total Funding: $80M

Aktis Oncology

Series A

Total Funding: $160M

Iconic Therapeutics

Series B

Total Funding: $74M

Semma Therapeutics

Series A

Total Funding: $44M

Clinical Ink

Series Unknown

Total Funding: $20M

Chiasma

Series C

Total Funding: $160M

Selexys Pharmaceuticals Corporation

Series A

Total Funding: $23M

Celladon

Series Unknown

Total Funding: $10M

Work Experience

MB
MPM BioImpact

1999

  • Managing Director

    1999

G
Genentech

1998 - 1998

  • Business Development Intern

    1998 - 1998

AD
Arthur D. Little

1994 - 1997

  • Analyst

    1994 - 1997